General Commentary

Published on 11 Jun 2024

Commentary: Mesenchymal stem cells in the treatment of spinal cord injury: mechanisms, current advances and future challenges

in Multiple Sclerosis and Neuroimmunology

Sabino Luzzi
Antonio Crovace
Alberto M. Crovace

Frontiers in Immunology

doi 10.3389/fimmu.2024.1354118

564 views

Review

Published on 11 Jun 2024

Exposing the latent phenotype of Gulf War Illness: examination of the mechanistic mediators of cognitive dysfunction

in Multiple Sclerosis and Neuroimmunology

Hannah E. Burzynski
Lawrence P. Reagan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1403574

587 views

Original Research

Published on 10 Jun 2024

Unveiling Immune-related feature genes for Alzheimer’s disease based on machine learning

in Multiple Sclerosis and Neuroimmunology

Guimei Zhang
Shuo Sun
Yingying Wang
Yang Zhao
Li Sun

Frontiers in Immunology

doi 10.3389/fimmu.2024.1333666

898 views

Brief Research Report

Published on 10 Jun 2024

Albumin and multiple sclerosis: a prospective study from UK Biobank

in Multiple Sclerosis and Neuroimmunology

Ke Chen
Chunyu Li
Bi Zhao
Huifang Shang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1415160

962 views

Original Research

Published on 07 Jun 2024

A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression

in Multiple Sclerosis and Neuroimmunology

Maria Inmaculada Dominguez-Mozo
Victoria Galán
Lluís Ramió-Torrentà
Ana Quiroga
E. Quintana
Luisa María Villar
Lucienne Costa-Frossard
José Ignacio Fernández-Velasco
Noelia Villarrubia
María Angel Garcia-Martinez

Frontiers in Immunology

doi 10.3389/fimmu.2024.1384411

930 views

Original Research

Published on 07 Jun 2024

Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Krizia Sanna
Antonio Bruno
Sara Balletta
Silvia Caioli
Monica Nencini
Diego Fresegna
Livia Guadalupi
Ettore Dolcetti
Federica Azzolini
Fabio Buttari

Frontiers in Immunology

doi 10.3389/fimmu.2024.1416133

844 views

Editorial

Published on 05 Jun 2024

Editorial: Gut dysbiosis-induced systemic inflammation in neurological diseases and disorders

in Multiple Sclerosis and Neuroimmunology

Pradeep Kumar Shukla
Shirin Fatma
Mohammad Moshahid Khan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1437651

1,141 views

Original Research

Published on 05 Jun 2024

Evaluating the link between immune characteristics and attention deficit hyperactivity disorder through a bi-directional Mendelian randomization study

in Multiple Sclerosis and Neuroimmunology

Hu Jue
Chen Dan-fei
Li Fang-fang
Yu Ke-pin
Xu Jia-ye
Zhang Hui-ting
Xuan Xiao-bo
Chen Jian

Frontiers in Immunology

doi 10.3389/fimmu.2024.1367418

1,361 views

Case Report

Published on 03 Jun 2024

Case report: Overlap syndrome of neuromyelitis optica spectrum disorder with anti-Argonaute antibodies

in Multiple Sclerosis and Neuroimmunology

Pei Liu
Xuemei Lin
Songdi Wu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1366531

912 views

Review

Published on 28 May 2024

Emergence of the brain-border immune niches and their contribution to the development of neurodegenerative diseases

in Multiple Sclerosis and Neuroimmunology

Li Yang Tan
Grace Cunliffe
Michael Patrick Hogan
Xin Yi Yeo
Chansik Oh
Bohwan Jin
Junmo Kang
Junho Park
Min-Soo Kwon
MinYoung Kim

Frontiers in Immunology

doi 10.3389/fimmu.2024.1380063

1,708 views

Original Research

Published on 24 May 2024

Evaluation of the causal effects of immune cells on ischemic stroke: a Mendelian randomization study

in Multiple Sclerosis and Neuroimmunology

Kunyu Wang
Beilin Zhang
Min Li
Hanying Duan
Zhuoya Jiang
Su Gao
Jing Chen
Shaokuan Fang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1374350

1,547 views
1 citation

Case Report

Published on 23 May 2024

Recurrent CNTN1 antibody-positive nodopathy: a case report and literature review

in Multiple Sclerosis and Neuroimmunology

Min Zhao
Guixian Chen
Shuguang Li
Xiaojun Li
Haoxuan Chen
Zhenzhen Lou
Huiying Ouyang
Yibo Zhan
Chenghao Du
Yuanqi Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1368487

872 views

Editorial

Published on 23 May 2024

Editorial: Neuroimmune cell signaling in COVID-19

in Multiple Sclerosis and Neuroimmunology

Kiarash Saleki
Zahra Mojtahedi
Timo Ulrichs
Mehdi Mahdavi
Abbas Azadmehr

Frontiers in Immunology

doi 10.3389/fimmu.2024.1429908

959 views

Original Research

Published on 23 May 2024

CAP2 contributes to Parkinson’s disease diagnosed by neutrophil extracellular trap-related immune activity

in Multiple Sclerosis and Neuroimmunology

Xiaohe Li
Meiling Luo
Hangrui Xu
Lei Jia
Yanan Liang
Qianxi Xu
Yonghui Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1377409

871 views

Brief Research Report

Published on 22 May 2024

Elevated serum levels of anti-collagen type I antibodies in patients with spontaneous cervical artery dissection and ischemic stroke: a prospective multicenter study

in Multiple Sclerosis and Neuroimmunology

Silke Zimmermann
Markus Weißenfels
Norma Krümmer
Wolfgang Härtig
Gesa Weise
Daniela Branzan
Dominik Michalski
Johann Otto Pelz

Frontiers in Immunology

doi 10.3389/fimmu.2024.1348430

648 views

Original Research

Published on 21 May 2024

A helping HAND: therapeutic potential of MAGL inhibition against HIV-1-associated neuroinflammation

in Multiple Sclerosis and Neuroimmunology

Alexis F. League
Barkha J. Yadav-Samudrala
Ramya Kolagani
Calista A. Cline
Ian R. Jacobs
Jonathan Manke
Micah J. Niphakis
Benjamin F. Cravatt
Aron H. Lichtman
Bogna M. Ignatowska-Jankowska

Frontiers in Immunology

doi 10.3389/fimmu.2024.1374301

1,449 views

Navigation group

Articles

Commentary: Mesenchymal stem cells in the treatment of spinal cord injury: mechanisms, current advances and future challenges

Exposing the latent phenotype of Gulf War Illness: examination of the mechanistic mediators of cognitive dysfunction

Unveiling Immune-related feature genes for Alzheimer’s disease based on machine learning

Albumin and multiple sclerosis: a prospective study from UK Biobank

A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression

Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis

Editorial: Gut dysbiosis-induced systemic inflammation in neurological diseases and disorders

Evaluating the link between immune characteristics and attention deficit hyperactivity disorder through a bi-directional Mendelian randomization study

Case report: Overlap syndrome of neuromyelitis optica spectrum disorder with anti-Argonaute antibodies

Emergence of the brain-border immune niches and their contribution to the development of neurodegenerative diseases

Evaluation of the causal effects of immune cells on ischemic stroke: a Mendelian randomization study

Recurrent CNTN1 antibody-positive nodopathy: a case report and literature review

Editorial: Neuroimmune cell signaling in COVID-19

CAP2 contributes to Parkinson’s disease diagnosed by neutrophil extracellular trap-related immune activity

Elevated serum levels of anti-collagen type I antibodies in patients with spontaneous cervical artery dissection and ischemic stroke: a prospective multicenter study

A helping HAND: therapeutic potential of MAGL inhibition against HIV-1-associated neuroinflammation